We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.02B
AUM Growth
-$31.8M
Cap. Flow
-$14.7M
Cap. Flow %
-0.37%
Top 10 Hldgs %
55.91%
Holding
627
New
130
Increased
130
Reduced
70
Closed
208
Avg Time Held Equity + Options
3.7 quarters
Top 10 Avg Time Held Equity + Options
1.3 quarters
Top 20 Avg Time Held Equity + Options
1.5 quarters
Avg Time Held Equity only
3.8 quarters
Top 10 Avg Time Held Equity only
1.3 quarters
Top 20 Avg Time Held Equity only
1.5 quarters

Top Buys

Rank Stock Value
1
DFS icon
Discover Financial Services
DFS
+$191M
2
SMAR icon
Smartsheet Inc.
SMAR
+$188M
3
FYBR icon
Frontier Communications
FYBR
+$124M
4
SUM icon
Summit Materials, Inc. Class A Common Stock
SUM
+$95M
5
ALTR icon
Altair Engineering Inc
ALTR
+$92.6M

Top Sells

Rank Stock Value
1
CTLT icon
CATALENT, INC.
CTLT
+$234M
2
MRO icon
Marathon Oil Corporation
MRO
+$222M
3
SRCL icon
Stericycle Inc
SRCL
+$172M
4
AXNX icon
Axonics, Inc. Common Stock
AXNX
+$150M
5
PRFT icon
Perficient Inc
PRFT
+$79.6M

Sector Composition

Rank Sector Weight
1 Technology 28.76%
2 Energy 15.79%
3 Communication Services 7.77%
4 Consumer Staples 7.72%
5 Financials 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
RAPT icon
351
DELISTED
RAPT Therapeutics
RAPT
$63.2K ﹤0.01%
+5,000
New +$63.5K
2024 Q4
0 quarters
FE icon
352
PUT
FirstEnergy
FE
$26B
$59.8K ﹤0.01%
26,000
– –
2024 Q2
2 quarters
DTIL icon
353
Precision BioSciences
DTIL
$185M
$59.2K ﹤0.01%
15,534
+2,805
+22% +$20.5K
2022 Q2
10 quarters
COO icon
354
PUT
Cooper Companies
COO
$10.3B
$55.8K ﹤0.01%
+12,000
New +$1.22M
2024 Q4
0 quarters
XBI icon
355
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$55.5K ﹤0.01%
90,000
-45,000
-33% -$4.36M
2023 Q3
5 quarters
IWM icon
356
CALL
iShares Russell 2000 ETF
IWM
$78.5B
$55.5K ﹤0.01%
45,000
-115,000
-72% -$26.2M
2024 Q3
1 quarter
TGTX icon
357
CALL
TG Therapeutics
TGTX
$8.48B
$55K ﹤0.01%
40,000
+20,000
+100% +$574K
2023 Q4
4 quarters
CAPR icon
358
CALL
Capricor Therapeutics
CAPR
$455M
$54K ﹤0.01%
+30,000
New +$526K
2024 Q4
0 quarters
CCL icon
359
PUT
Carnival Corporation Ltd
CCL
$35.4B
$51.1K ﹤0.01%
500,000
-391,500
-44% -$9.16M
2021 Q3
13 quarters
DYN icon
360
CALL
Dyne Therapeutics
DYN
$3.11B
$49K ﹤0.01%
+20,000
New +$592K
2024 Q4
0 quarters
IRTC icon
361
CALL
iRhythm Holdings
IRTC
$3.52B
$44.5K ﹤0.01%
+15,000
New +$1.18M
2024 Q4
0 quarters
IMCR icon
362
CALL
Immunocore
IMCR
$1.51B
$42.9K ﹤0.01%
+17,500
New +$553K
2024 Q4
0 quarters
SYF icon
363
PUT
Synchrony
SYF
$23.7B
$42.2K ﹤0.01%
21,900
– –
2024 Q2
2 quarters
PRAX icon
364
CALL
Praxis Precision Medicines
PRAX
$7.26B
$41.8K ﹤0.01%
10,000
-3,000
-23% -$217K
2024 Q3
1 quarter
XLV icon
365
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$44.2B
$37.5K ﹤0.01%
+60,000
New +$8.78M
2024 Q4
0 quarters
VERA icon
366
CALL
Vera Therapeutics
VERA
$2.15B
$36K ﹤0.01%
+15,000
New +$664K
2024 Q4
0 quarters
AGEN icon
367
Agenus
AGEN
$346M
$35.3K ﹤0.01%
12,888
-10,000
-44% -$37K
2024 Q2
2 quarters
QURE icon
368
CALL
uniQure
QURE
$1.57B
$31.6K ﹤0.01%
+115,000
New +$993K
2024 Q4
0 quarters
KPTI icon
369
CALL
Karyopharm Therapeutics
KPTI
$13.7M
$30K ﹤0.01%
+26,667
New +$322K
2024 Q4
0 quarters
RGNX icon
370
CALL
Regenxbio
RGNX
$533M
$30K ﹤0.01%
+80,000
New +$751K
2024 Q4
0 quarters
CYH icon
371
CALL
Community Health Systems
CYH
$389M
$27K ﹤0.01%
+270,000
New +$1.13M
2024 Q4
0 quarters
SNDX icon
372
PUT
Syndax Pharmaceuticals
SNDX
$1.52B
$25K ﹤0.01%
+100,000
New +$1.71M
2024 Q4
0 quarters
BAX icon
373
CALL
Baxter International
BAX
$12.6B
$23.8K ﹤0.01%
+50,000
New +$1.68M
2024 Q4
0 quarters
XAGEW
374
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
$21.3K ﹤0.01%
371,250
– –
2023 Q3
5 quarters
INCY icon
375
CALL
Incyte
INCY
$22.9B
$19.5K ﹤0.01%
+20,000
New +$1.43M
2024 Q4
0 quarters
13 14
15
16 17

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q4 2024 Portfolio in Review

As of Q4 2024, UBS O'Connor held 627 positions worth $4.02B, down 0.79% from $4.05B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor's Q4 2024 filing shows 130 new, 130 increased, 70 reduced and 208 closed positions. Its largest new stake was Discover Financial Services: 1,166,698 shares worth $202M. The largest sale was CATALENT, INC., an estimated $234M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 20% a quarter earlier, followed by Energy and Communication Services.

  • UBS O'Connor's largest Q4 2024 buy was Discover Financial Services: 1,166,698 shares worth $202M.
  • UBS O'Connor added most to Smartsheet Inc. in Q4 2024, an estimated $188M increase.
  • UBS O'Connor's biggest Q4 2024 reduction was US Steel, cutting an estimated $62.2M.
  • UBS O'Connor fully exited CATALENT, INC. in Q4 2024, selling an estimated $234M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.02B portfolio in Q4 2024.
  • UBS O'Connor opened 130 new positions and closed 208 in Q4 2024.
  • UBS O'Connor's portfolio value fell 0.79% quarter-over-quarter to $4.02B.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.